mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-09 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-08 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-08 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
5e-08 |
mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
6e-08 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-08 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.35 |
1e-07 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-07 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-07 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |